Grusovin M G, Coulthard P, Jourabchian E, Worthington H V, Esposito M A B
School of Dentistry, Department of Oral and Maxillofacial Surgery, University of Manchester, Higher Cambridge Street, Manchester, UK M15 6FH.
Cochrane Database Syst Rev. 2008 Jan 23(1):CD003069. doi: 10.1002/14651858.CD003069.pub3.
It is important to institute an effective supportive therapy to maintain or recover soft tissue health around dental implants. Different maintenance regimens have been suggested, however it is unclear which are the most effective.
To test the null hypotheses of no difference between different interventions (1) for maintaining healthy peri-implant soft tissues, and (2) for recovering soft tissue health, against the alternative hypothesis of a difference.
We searched the Cochrane Oral Health Group's Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE and EMBASE. Handsearching included several dental journals. We checked the bibliographies of the identified randomised controlled trials (RCTs) and relevant review articles for studies outside the handsearched journals. We wrote to authors of all identified RCTs, to more than 55 oral implant manufacturers and to an internet discussion group to find unpublished or ongoing RCTs. No language restrictions were applied. The last electronic search was conducted on 13 June 2007.
All randomised controlled trials comparing agents or interventions for maintaining or recovering healthy tissues around dental implants.
Screening of eligible studies, assessment of the methodological quality of the trials and data extraction were conducted in duplicate and independently by two review authors. Results were expressed as random-effects models using standardised mean differences for continuous data and risk ratios for dichotomous data with 95% confidence intervals.
Eighteen RCTs were identified. Nine of these trials, which reported results from a total of 238 patients, were included. Follow ups ranged between 6 weeks and 1 year. No meta-analysis could be made since every RCT tested different interventions. Listerine mouthwash showed a reduction of 54% in plaque and 34% in marginal bleeding compared with a placebo. Two trials evaluated the efficacy of powered and sonic toothbrushes compared to manual toothbrushing and showed no statistically significant differences, though more patients liked the sonic brush. No statistical differences were found between brushing with a hyaluronic or a chlorhexidine gel, between cleaning with an etching gel or manually, between injecting a chlorhexidine or a physiologic solution inside the implant's inner part and between submucosal minocycline and a chlorhexidine gel. When an amine fluoride/stannous fluoride (AmF/SnF(2)) mouthrinse was compared with a chlorhexidine one, no statistically significant differences were found for implant failures and staining index while patients preferred and had less taste change with the AmF/SnF(2) mouthrinse. Self administered subgingival chlorhexidine irrigation resulted in statistically significantly lower plaque and marginal bleeding than a chlorhexidine mouthwash, however the mouthwash was given at a suboptimal dosage.
AUTHORS' CONCLUSIONS: There was only little reliable evidence for which are the most effective interventions for maintaining or recovering health of peri-implant soft tissues. The included RCTs had short follow-up periods and few subjects. There was not any reliable evidence for the most effective regimens for long term maintenance. This should not be interpreted as current maintenance regimens are ineffective. There was weak evidence that Listerine mouthwash, used twice a day for 30 seconds, as an adjunct to routine oral hygiene, is effective in reducing plaque and marginal bleeding around implants. More RCTs should be conducted in this area. In particular, there is a definite need for trials powered to find possible differences, using primary outcome measures and with much longer follow up. Such trials should be reported according to the CONSORT guidelines (http://www.consort-statement.org/).
开展有效的支持性治疗以维持或恢复牙种植体周围软组织健康非常重要。已提出了不同的维护方案,但尚不清楚哪些方案最为有效。
检验不同干预措施在(1)维持健康的种植体周围软组织和(2)恢复软组织健康方面无差异的无效假设,备择假设为存在差异。
我们检索了Cochrane口腔健康组试验注册库、Cochrane对照试验中央注册库(CENTRAL)、MEDLINE和EMBASE。手工检索包括几种牙科杂志。我们检查了已识别的随机对照试验(RCT)的参考文献以及相关综述文章,以查找手工检索杂志之外的研究。我们写信给所有已识别RCT的作者、55多家口腔种植体制造商以及一个互联网讨论组,以查找未发表或正在进行的RCT。未设语言限制。最后一次电子检索于2007年6月13日进行。
所有比较用于维持或恢复牙种植体周围健康组织的药物或干预措施的随机对照试验。
由两位综述作者独立进行重复筛选符合条件的研究、评估试验的方法学质量以及数据提取。结果以随机效应模型表示,连续数据采用标准化均数差,二分数据采用风险比,并给出95%置信区间。
共识别出18项RCT。其中9项试验纳入分析,这些试验共报告了238例患者的结果。随访时间为6周至1年。由于每项RCT测试的干预措施不同,因此无法进行荟萃分析。与安慰剂相比,李斯德林漱口水使牙菌斑减少54%,边缘性出血减少34%。两项试验评估了电动牙刷和声波牙刷与手动牙刷相比的效果,结果显示无统计学显著差异,不过更多患者喜欢声波牙刷。用透明质酸凝胶或洗必泰凝胶刷牙、用蚀刻凝胶清洁或手动清洁、在种植体内注入洗必泰或生理溶液以及使用黏膜下米诺环素和洗必泰凝胶之间均未发现统计学差异。当将胺氟化物/氟化亚锡(AmF/SnF₂)漱口水与洗必泰漱口水进行比较时,在种植体失败率和染色指数方面未发现统计学显著差异,不过患者更喜欢AmF/SnF₂漱口水,且味觉改变较少。自我进行龈下洗必泰冲洗导致牙菌斑和边缘性出血在统计学上显著低于洗必泰漱口水,不过漱口水的给药剂量未达最佳。
关于哪些是维持或恢复种植体周围软组织健康的最有效干预措施,仅有很少的可靠证据。纳入的RCT随访期短且受试者少。对于长期维护的最有效方案,没有任何可靠证据。这不应该被解释为当前的维护方案无效。有微弱证据表明,作为常规口腔卫生的辅助措施,每天使用两次、每次30秒的李斯德林漱口水可有效减少种植体周围的牙菌斑和边缘性出血。该领域应开展更多RCT。特别是,绝对需要进行有足够效力以发现可能差异的试验,采用主要结局指标并进行更长时间的随访。此类试验应按照CONSORT指南(http://www.consort-statement.org/)进行报告。